Generate a reference-grade genome assembly
Build a reference-grade assembly capable of supporting structural variant analysis and downstream regulatory and transcriptomic integration.
How CD Genomics translated a preliminary sequencing request into a coordinated, execution-ready multi-omics project.
A research team approached CD Genomics with a preliminary long-read sequencing proposal intended to support genome assembly, structural characterization, and downstream regulatory studies. We recognized that treating it as a stand-alone sequencing order could produce fragmented datasets that would be difficult to integrate.
After evaluating genomic complexity, target assembly metrics, available scaffolding data, and input DNA constraints, we converted the initial concept into a coordinated workflow integrating high-fidelity long-read sequencing, chromosome-level Hi-C scaffolding, and parallel ATAC-seq/RNA-seq profiling.
De novo genome assembly coupled with ATAC-seq and RNA-seq represents the gold standard for decoding the genotype-to-phenotype axis. By mapping chromatin accessibility and transcriptomic data directly to a custom, high-quality de novo reference, researchers eliminate the mapping biases associated with using divergent reference genomes, enabling highly precise multi-layer regulatory analysis.
Privacy Note: To preserve client confidentiality, this case study focuses strictly on solution architecture, bioinformatics logic, and project governance. All identifying metadata and biological findings have been fully anonymized.
Build a reference-grade assembly capable of supporting structural variant analysis and downstream regulatory and transcriptomic integration.
We assessed feasibility, benchmarked sequencing platforms, defined the computational scope, and mapped the dependencies between assays.
An integrated project blueprint with defined workflow specifications, QC gateways, and data-handoff requirements before sample processing.
Before finalizing the workflow, our bioinformatics and sequencing specialists worked with the client to align biological goals, wet-lab constraints, and computational requirements:
Which sequencing platform and read-depth best satisfy the target contiguity and downstream analytical requirements?
How do we ensure multi-omics datasets (ATAC/RNA) map harmoniously to the newly assembled reference without batch or reference bias?
Which analytical modules fit within our standardized pipelines, and where is custom bioinformatics algorithm development required?
What are the prerequisite data metrics and QC thresholds required to trigger subsequent assay modules?
At which computational milestones must the client review intermediate outputs to approve downstream workstreams?
We translated the client’s biological objectives into a defined, data-connected multi-omics architecture.
The client needed an assembly supporting high-resolution SV detection and serving as a reliable anchor for chromatin and transcriptomic profiling.
Before discussing sequencing platforms, we defined the “success criteria.” We established target contiguity metrics, assessed the need for haplotype phasing, and mapped out exactly how the ATAC and RNA data would consume the final genome assembly.
Validating whether the client’s initial long-read concept could deliver the required resolution.
We evaluated technical bottlenecks: highly homologous genomic segments, repeat-rich regions, and the trade-off between read length and base accuracy. We recommended upgrading to high-accuracy long-read sequencing (HiFi) coupled with Hi-C for chromosome-level scaffolding, ensuring optimal resolution of complex regions and precise chromosomal anchoring.
Unambiguous demarcation between standard workflows, custom bioinformatics development, and strict QC standards.
Our cross-functional teams generated a consolidated blueprint. We defined sample eligibility criteria, expected assembly metrics, and isolated highly specific analytical requests into documented custom bioinformatics modules.
Preventing “data silos” where disjointed omics datasets lack a unified analytical baseline.
We built a Data Dependency Blueprint. We harmonized sample grouping, quality thresholds, and data handoffs. We ensured that upstream genome assembly outputs seamlessly fed into downstream ATAC and RNA mapping algorithms.
Providing the client with full visibility across interdependent wet-lab and dry-lab workflows.
We implemented milestone-tied updates anchored to objective checkpoints (Sample QC → Library Prep → Sequencing Yield → Assembly Graph Generation → Final Integration).
We design workflows where each technology fulfills a distinct biological role, maximizing scientific yield when jointly analyzed:
Establishes the nucleotide-level foundation. Crucial for traversing highly repetitive regions, resolving complex structural variations (SVs), and generating a highly contiguous primary assembly.
Delivers long-range chromatin interaction data. Essential for elevating contigs to chromosome-level scaffolds and validating the structural integrity of the genome assembly.
Profiles the accessible chromatin landscape. Mapped directly against the newly assembled de novo reference to identify cis-regulatory elements (enhancers, promoters) with high precision.
Quantifies genome-wide gene expression. Supports differential expression and Gene Regulatory Network (GRN) modeling by correlating transcript abundance with chromatin accessibility signals.
A highly optimized technical route supported by sequencing and computational rationale.
Explicit mapping of how genome assembly outputs feed into regulatory and transcriptomic pipelines.
Clear separation between standardized bioinformatics pipelines and custom algorithmic development.
Objective quality review points to validate data readiness before launching downstream modules.
Milestone-based status updates anchoring client visibility across both wet-lab and computational phases.
We define what the research needs to resolve before recommending the technical route.
We bring wet-lab, sequencing, consulting, and bioinformatics perspectives into one plan.
We plan how outputs become inputs so connected assays share a usable analytical framework.
We define scope, quality gates, responsibilities, and review points before dependent work proceeds.
Complex de novo genome and multi-omics projects require coordinated decisions across sample quality, genome complexity, reference resources, sequencing design, and downstream computation. If you are planning a de novo assembly or an integrated regulatory study, share your biological objectives, sample constraints, and key research questions with our sequencing and bioinformatics specialists so we can help define a robust workflow before sample submission.
Terms & Conditions Privacy Policy Copyright © CD Genomics. All rights reserved.